Evaluation of biomarkers and surrogate endpoints in chronic disease /

Saved in:
Bibliographic Details
Imprint:Washington, D.C. : National Academies Press, c2010.
Description:xx, 314 p. : ill. ; 23 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/8136510
Hidden Bibliographic Details
Other authors / contributors:Micheel, Christine.
Ball, John, 1944-
Institute of Medicine (U.S.). Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease.
ISBN:9780309151290 (pbk.)
0309151295 (pbk.)
9780309151306 (pdf)
0309151309 (pdf)
Notes:Includes bibliographical references.
Summary:"Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process."--Publisher's description.

Similar Items